| abstract |
(57) [Summary] [Structure] As the active ingredient, the formula: Where R 2 is C 1 -C optionally substituted in the alkyl chain moiety with one or more aromatic groups. 20 straight or branched chain hydroxyalkyl groups, and 1 To an alcohol residue selected from hydroxyaryl groups optionally substituted by one or more straight or branched chain alkyl groups having 20 carbon atoms, and R 3 is H or = R 2 And Is an acyl group, an N-acyl derivative of an amino alcohol, for the treatment or prophylaxis of both human or animal pathologies with mast cell degranulation as a result of hyperstimulation of neurogens and / or immunogens. Composition. [Effect] The pharmaceutical composition of the present invention is suitable for all humans and animals having an autoimmune origin characterized by mast cell hyperstimulation and required to regulate the degranulation reaction induced by neurogenic immunostimulation. Effective in treating medical conditions. |